Amanda Forys, Partner, Magnolia Market Access
Forys’ consulting and manufacturer experience has covered a wide range of commercialization topics, including health policy, pricing and rebating, coding, coverage and reimbursement, health economics, budget impact modeling, patient assistance design, and training for specialty pharmaceuticals, biosimilars, organ transplantation, and devices.
Susan Gaffney, Executive Vice President of Membership, Development, and Events, National Health Council
After nearly 30 years of experience working with non-profits across the country, Susan Gaffney joined the National Health Council in March 2020 and is now its Executive Vice President of Membership, Development, and Events. Gaffney provides strategic direction for the groups fundamental work of ensuring that its robust membership is engaged and supported while tackling the critical issues related to chronic health conditions, which are at the heart of the NHC’s mission.
Gaffney’s progressive experience in both the health and non-profit sectors allows her to draw on a range of skills and experiences in helping to drive the NHC’s work. Previously, Gaffney had been the National Director of Membership and Governance at NAMI, the National Alliance on Mental Illness, where she focused on nonprofit governance, compliance, strategy, and member support.
She has also worked in a variety of roles in the nonprofit education and health sectors in Washington, DC, New York, and San Francisco including the Department of Child and Adolescent Psychiatry at Columbia University College of Physicians and Surgeons
and the Mount Sinai Adolescent Health Center. Gaffney earned a master’s in Nonprofit Management and Public Policy from the Milano School of Policy, Management, and Environment at The New School in New York City, and a bachelor’s in history from St. Bonaventure University. She is certified in Group Facilitation by the Institute of Cultural Affairs and as a Change Management Practitioner by Prosci.
Anna Hyde, Vice President of Advocacy and Access, Arthritis Foundation
She oversees both the federal and state legislative programs, in addition to grassroots engagement. Her focus is to raise the visibility of arthritis as a public health priority, build support for federal and state legislation that ensures access to affordable, high-quality healthcare, and enhance patient engagement in the policy-making process. Anna previously served as Senior Director of Advocacy and Access, managing the federal affairs portfolio and overseeing the state advocacy team. Prior to joining the Arthritis Foundation in 2014, Anna worked as Senior Manager for Federal Affairs at the American Congress of Obstetricians and Gynecologists, where she managed a portfolio of issues including appropriations, physician workforce, and health IT. She began her health policy career as a Congressional Fellow for Energy and Commerce Committee members, where she drafted legislation and staffed Committee activities. Anna received a BA in History from Southern Methodist University and taught junior high and high school history before moving to Washington, DC in 2007 to pursue an MA in Political Science from American University.
Sarah Ikenberry, Senior Communication Advisor, Office of Therapeutic Biologics and Biosimilars (OTBB) at the U.S. Food and Drug Administration (FDA)
Sarah Ikenberry is a Senior Communication Advisor for the Office of Therapeutic Biologics and Biosimilars (OTBB) in the Food and Drug Administration’s (FDA) Center for Evaluation and Research (CDER) where she provides communication advice and support to senior leaders and the agency about communicating strategic priorities, initiatives, and information about biosimilar and interchangeable products. She also manages stakeholder education and outreach activities for OTBB. Sarah has a Master of Arts in Communication from Johns Hopkins University
Juliana M. Reed, Executive Director, The Biosimilars Forum
Reed has served as the Biosimilars Forum president for more than eight years and was one of its original co-founders. She brings more than 30 years of experience in the healthcare sector to the Forum and has served in executive roles leading global corporate and government affairs for Pfizer, Hospira and Coherus BioSciences.
As the Biosimilars Forum president, Reed oversaw advocacy and awareness campaigns to advance biosimilar access and adoption in the United States.